116 related articles for article (PubMed ID: 12504052)
1. Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16 Gy.
Gerling J; Kommerell G; Henne K; Laubenberger J; Schulte-Mönting J; Fells P
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):182-9. PubMed ID: 12504052
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy.
Johnson KT; Wittig A; Loesch C; Esser J; Sauerwein W; Eckstein AK
Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):103-9. PubMed ID: 19865824
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study.
Mourits MP; van Kempen-Harteveld ML; García MB; Koppeschaar HP; Tick L; Terwee CB
Lancet; 2000 Apr; 355(9214):1505-9. PubMed ID: 10801172
[TBL] [Abstract][Full Text] [Related]
4. Perspective--Part III: retrobulbar irradiation in Graves orbitopathy: the Dutch experience.
Wiersinga WM
Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):175-6. PubMed ID: 12021646
[No Abstract] [Full Text] [Related]
5. [Retrobulbar irradiation of endocrine ophthalmopathy: a comparison between 10 and 16 Gy total dose].
Pfluger T; Wendt T; Toroutoglou N; Pickardt C; Wuttge R
Strahlenther Onkol; 1990 Oct; 166(10):673-7. PubMed ID: 2237752
[TBL] [Abstract][Full Text] [Related]
6. [Conformal irradiation technique for the peri- and retrobulbar space in endocrine orbitopathy].
Götz U; Schwab FJ; Bratengeier K; Schicker B; Kiricuta IC
Z Med Phys; 2001; 11(3):201-4. PubMed ID: 11668818
[TBL] [Abstract][Full Text] [Related]
7. Place of radiotherapy in the treatment of Graves' orbitopathy.
Beckendorf V; Maalouf T; George JL; Bey P; Leclere J; Luporsi E
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):805-15. PubMed ID: 10098436
[TBL] [Abstract][Full Text] [Related]
8. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
Howarth D; Epstein M; Lan L; Tan P; Booker J
Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
[TBL] [Abstract][Full Text] [Related]
9. The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves' orbitopathy.
Akmansu M; Dirican B; Bora H; Gurel O
Ophthalmic Res; 2003; 35(3):150-3. PubMed ID: 12711842
[TBL] [Abstract][Full Text] [Related]
10. Orbital irradiation for thyroid-associated orbitopathy: conventional dose, low dose or no dose?
Perros P; Krassas GE
Clin Endocrinol (Oxf); 2002 Jun; 56(6):689-91. PubMed ID: 12072037
[No Abstract] [Full Text] [Related]
11. [Retrobulbar irradiation for Graves' ophthalmopathy -- long-term results].
Pitz S; Kahaly G; Rösler HP; Krummenauer F; Wagner B; Stübler M; Pfeiffer N
Klin Monbl Augenheilkd; 2002 Dec; 219(12):876-82. PubMed ID: 12548473
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonically measured horizontal eye muscle thickness in thyroid associated orbitopathy: cross-sectional and longitudinal aspects in a Danish series.
Fledelius HC; Zimmermann-Belsing T; Feldt-Rasmussen U
Acta Ophthalmol Scand; 2003 Apr; 81(2):143-50. PubMed ID: 12752052
[TBL] [Abstract][Full Text] [Related]
13. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute Graves orbitopathy.
Kazim M; Trokel S; Moore S
Ophthalmology; 1991 Sep; 98(9):1443-8. PubMed ID: 1945322
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.
Prummel MF; Terwee CB; Gerding MN; Baldeschi L; Mourits MP; Blank L; Dekker FW; Wiersinga WM
J Clin Endocrinol Metab; 2004 Jan; 89(1):15-20. PubMed ID: 14715820
[TBL] [Abstract][Full Text] [Related]
16. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy.
Prummel MF; Mourits MP; Blank L; Berghout A; Koornneef L; Wiersinga WM
Lancet; 1993 Oct; 342(8877):949-54. PubMed ID: 8105213
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of irradiation for patients with progressive Graves' ophthalmopathy.
Marquez SD; Lum BL; McDougall IR; Katkuri S; Levin PS; MacManus M; Donaldson SS
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):766-74. PubMed ID: 11697323
[TBL] [Abstract][Full Text] [Related]
18. The effect of retrobulbar irradiation on exophthalmos, ductions and soft tissue signs in Graves' ophthalmopathy: a retrospective analysis of 90 cases.
Van Ruyven RL; Van Den Bosch WA; Mulder PG; Eijkenboom WM; Paridaens AD
Eye (Lond); 2000 Oct; 14 Pt 5():761-4. PubMed ID: 11116700
[TBL] [Abstract][Full Text] [Related]
19. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
[TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy only in severe, progressive endocrine orbitopathy: long-term results and comparison of various classification systems].
Gusek-Schneider GC; Seegenschmiedt MH; Jünemann A; Keilholz L; Becker W; Hensen J
Klin Monbl Augenheilkd; 1998 Aug; 213(2):74-80. PubMed ID: 9782464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
